Behcet’s Syndrome Market Analysis By Type(Ocular-Behcet, Vasculo-Behcet, Neuro-Behcet), By Route of Administration(Oral, Injectable) & Forecast
- PUBLISHED ON
- 2024-10-03
- NO OF PAGES
- 257
- CATEGORY
- Healthcare & Life Sciences
Main factors that boost the market growth are the growth in incidences of Behcets disease worldwide. For instance, as per the American Behcets Disease Association (ABDA) there are roughly 16,000-20,000 cases of Behcet's disease in the U.S. and this disease is most dominant in Turkey in which almost 400 cases for each 100,000 individuals have been witnessed.
In addition, numerous major players are concentrating on the pathogenesis of the disease for the development of efficient therapeutic selections that expand results and prevent irrevocable organ damage. This, in turn, is more creating an optimistic outlook for the market. Moreover, the developing popularity of modified treatment methods for handling the disease, depending on the organs involved, the severity and period of involvement, the occurrence of attacks, gender, and the patient's age, is also a significant growth-inducing factor.
Covid-19 had a key impact on almost all industries, such as chemical, healthcare, manufacturing, automobile, etc. But, several corporations operating in the technology sector have seen augmented revenue owing to substantial changes in consumer inclinations toward technological facilities. In addition, the disease has led to important growth in technology across emerging and developed nations. Moreover, the growth of this market is mostly driven due to the growth and progress in healthcare industry.
Type Insights
The type segment is ocular-Behcet, vasculo-Behcet, and neuro-Behcet. During the forecasted period, Neuro-Behcet are projected to grow at the fastest rate. A patient with Behcet's disease is supposed to have neurologic symptoms and/or marks of neuro-disease Behcet's (NBD) (BD). Related syndromes contain movement problems, cerebral venous sinus thrombosis (CVST), multiple sclerosis-like presentations, myelopathic syndrome, meningoencephalitic syndrome, and intracranial hypertension. During the forecasted period, Neuro-illness Behcet's prevalence is possibly going to be the segment's major driver.
Route of Administration Insights
The route of administration includes oral and injectable. The oral segment is anticipated to witness the highest CAGR during the forecasted period. For the behcet’s disease treatment the medicine is generally consumed orally which boosts the segments growth. Moreover, the injections are frequently used when the indications get worse which is barely the case as many symptoms are detected at earlier stage.
Region Insights
In 2021, North America appeared as the largest market for the global Behcet’s syndrome market, with a market share of about 42%. North America region witnessed a major share. Globally known companies like F. Hoffmann-La Roche Ltd., Pfizer Inc., 3M, and others are established in North America. The existence of such giants in the area has a substantial impact on the demand for behcet's disease treatment services. Moreover, the market is fuelled by the growing prevalence of behcet's disease in the region. Furthermore, immediate FDA approvals and improvements in R&D events are significant drivers of market growth for treatments for behcet's disease.
However, Asia Pacific is expected to witness the fastest growth rate during the forecasted period. The factors that are anticipated to grow the market are increasing Behcet's cases across the region. Moreover, Chinese people between the ages of 30-39 are most generally affected with Behcet's illness, which has a wide medical range and can include a range of severe internal organs. In Chinese populations, men experience the condition more often and with greater severity than women.
Key Companies Insights
The market for Behcet’s syndrome is moderately competitive. With the rising applications of Behcet’s syndrome, new players are considering to enter the market. The companies are also involved in activities like joint ventures, acquisitions, partnerships, mergers, and collaborations. These activities aid in growing the effect of the players in the Behcet’s syndrome market, ultimately boosting the market growth.
• Creabilis Ltd.
• Cell Medica Limited
• Actelion Ltd.
• Abbott Laboratories
• Novartis AG
• Les Laboratoires
• Servier SAS
• AbbVie Inc.
• Celgene Corporation
• F. Hoffmann-La Roche Ltd.
• XOMA
• Mitsubishi Tanabe Pharma Corporation
• Takeda Pharmaceutical Company Limited
• Coherus BioSciences
• Servier
• Lupin Pharmaceuticals Inc.
• Other players
Some of the Recent Developments:
• In October 2022, Pfizer Inc. concluded the acquisition of Global Blood Therapeutics, Inc. (GBT) that provide expectation to underserved patient groups starting with sickle cell disease (SCD). The acquisition strengthens Pfizer’s commitment to SCD.
• In December 2021, Novartis entered into a definitive agreement to purchase the UK-based ocular gene therapy company Gyroscope Therapeutics.
Segments
By Type
• Ocular-Behcet
• Vasculo-Behcet
• Neuro-Behcet
By Route of Administration
• Oral
• Injectable
By Geography
• North America
o U.S.
o Canada
o Mexico
• Europe
o U.K.
o Germany
o France
o Italy
o Spain
o Russia
• Asia-Pacific
o Japan
o China
o India
o Australia
o South Korea
o ASEAN
• Latin America
o Brazil
o Argentina
o Colombia
• MEA
o South Africa
o Saudi Arabia
o UAE
o Egypt
Quality Assurance Process
- We Market Research’s Quality Assurance program strives to deliver superior value to our clients.
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
- Project kickoff meeting with client
- Conduct frequent client communications
- Form project steering committee
- Assign a senior SR executive as QA Executive
- Conduct internal editorial & quality reviews of project deliverables
- Certify project staff in SR methodologies & standards
- Monitor client satisfaction
- Monitor realized value post-project
Case Study- Automotive Sector
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached We Market Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
Solution
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
Market Estimates and Forecast
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Case Study- ICT Sector
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
Business Solution
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
Conclusion
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2033.
}})
Select a license type that suits your business needs
US $3499
Only Three Thousand Four Hundred Ninety Nine US dollar
- 1 User access
- 15% Additional Free Customization
- Free Unlimited post-sale support
- 100% Service Guarantee until achievement of ROI
US $4499
Only Four Thousand Four Hundred Ninety Nine US dollar
- 5 Users access
- 25% Additional Free Customization
- Access Report summaries for Free
- Guaranteed service
- Dedicated Account Manager
- Discount of 20% on next purchase
- Get personalized market brief from Lead Author
- Printing of Report permitted
- Discount of 20% on next purchase
- 100% Service Guarantee until achievement of ROI
US $5499
Only Five Thousand Four Hundred Ninety Nine US dollar
- Unlimited User Access
- 30% Additional Free Customization
- Exclusive Previews to latest or upcoming reports
- Discount of 30% on next purchase
- 100% Service Guarantee until achievement of ROI